Akebia Therapeutics, Inc.

AX9.F·Frankfurt·Healthcare
Compare
0.5972−0.0322 (−5.12%)today
As of Nov 5, 8:04 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.6294
Open0.5972
Day range—
52-week range0.49441.7810
Off day high0.00%
Off 52-week high−66.47%
Volume900
Avg. volume (3M)0.00
Market cap165.49M
EPS (TTM)-0.1000
Forward P/E-0.77
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.18
Shares outstanding277.11M
Short interest—
Earnings dateNov 5, 2026
Analyst target—
Profit margin−13.54%

Against its peers

Compare in full ›
AX9.F 42C.SI BCRX GUD.TO B6E.F 002038.SZ
Market cap 165.49M 515.12M 2.11B 1.11B 15.44B 5.37B
P/E (TTM) — — — 75.3 25.6 —
Forward P/E -0.8 247.4 10.0 43.5 — —
Price/book 7.3 33.6 -14.7 1.4 0.4 1.1
Dividend yield — — — — — 0.19%
1-year change −65.57% +259.26% +17.21% +92.81% +43.32% −31.88%
Today −5.12% −3.09% −3.85% +0.36% +1.98% +1.55%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All AX9.F news ›
Stock Titan·

Akebia Therapeutics: Nicholas Grund to resign Nov. 6

The commercial chief at Akebia Therapeutics (AKBA) plans to resign for personal reasons. Stock Titan Akebia Therapeutics: Nicholas Grund to resign Nov. 6 Nicholas Grund's consulting engagement is scheduled to continue through April 30,…

MarketScreener·

Akebia Therapeutics, Inc. : Insider Transactions

Follow insider transactions on Akebia Therapeutics, Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Akebia Therapeutics, Inc. Latest insider transactions for…

From the 4Search news index, newest first.

In the news

16mentions in 30 days
16with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance